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Background: Portal biliopathy (PBP) denotes intra- and extrahepatic biliary duct abnormalities that
occur as a result of portal hypertension and is commonly seen in extrahepatic portal vein obstruction
(EHPVO). The management of symptomatic PBP is still controversial.
Methods: Prospectively collected data for surgically managed PBP patients from 1996 to 2007 were
retrospectively analysed for presentation, clinical features, imaging and the results of surgery. All patients
were assessed with a view to performing decompressive shunt surgery as a first-stage procedure and
biliary drainage as a second stage-procedure if required, based on evaluation at 6 weeks after shunt
surgery.
Results: A total of 39 patients (27 males, mean age 29.56 years) with symptomatic PBP were managed
surgically. Jaundice was the most common symptom. Two patients in whom shunt surgery was unsuitable
underwent a biliary drainage procedure. A total of 37 patients required a proximal splenorenal shunt as
first-stage surgery. Of these, only 13 patients required second-stage surgery. Biliary drainage procedures
(hepaticojejunostomy [n = 11], choledochoduodenostomy [n = 1]) were performed in 12 patients with
dominant strictures and choledocholithiasis. One patient had successful endoscopic clearance of
common bile duct (CBD) stones after first-stage surgery and required only cholecystectomy as a
second-stage procedure. The average perioperative blood product transfusion requirement in second-
stage surgery was 0.9 units and postoperative complications were minimal with no mortality. Over a mean
follow-up of 32.2 months, all patients were asymptomatic. Decompressive shunt surgery alone relieved
biliary obstruction in 24 of 37 patients (64.9%) and facilitated a safe second-stage biliary decompressive
procedure in the remaining 13 patients (35.1%).
Conclusions: Decompressive shunt surgery alone relieves biliary obstruction in the majority of patients
with symptomatic PBP and facilitates endoscopic or surgical management in patients who require
second-stage management of biliary obstruction.
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Introduction
The term ‘portal biliopathy’ (PBP) encompasses intra- and extra-
hepatic biliary duct and gallbladder wall abnormalities seen in
portal hypertension.The changes associated with PBP are common
in portal hypertension as a result of extrahepatic portal vein
obstruction (EHPVO),1–4 which accounts for up to 40% of cases of
portal hypertension in India.5,6 However, in most patients, PBP
remains asymptomatic and gives rise to obstructive jaundice only
in a minority (5–33%) of cases.1,3,7,8 Early and adequate alleviation
of the biliary obstruction in this condition is essential because it
appears to be a late9,10and progressive3 manifestation of EHPVO
and, if unrelieved, may lead to secondary biliary cirrhosis.11,12
This paper is based on a poster presented at the Eighth World Congress of
the International Hepato-Pancreato-Biliary Association, 22 February to 2
March 2008, Mumbai.
DOI:10.1111/j.1477-2574.2010.00232.x HPB
HPB 2011, 13, 33–39 © 2010 International Hepato-Pancreato-Biliary Association
The management of symptomatic PBP remains controversial
and various treatment options have been described in the litera-
ture. In this paper, we describe our institution’s experience in the
surgical treatment of patients with symptomatic PBP over a
period of 11 years (1996–2007) and present an algorithmic
approach to the management of these patients. To the best of our
knowledge, this is the largest series of surgically treated PBP
patients to be reported.
Materials and methods
Prospectively collected data pertaining to patients with symptom-
atic PBP, who were treated surgically over an 11-year period from
June 1996 to December 2007, were analysed retrospectively.
Patients with malignancy as the cause of either portal vein
obstruction or biliary symptoms were excluded from the study.
Investigation of these patients consisted of routine haemato-
logic investigations, liver function tests (LFTs), cholangiography
in the form of magnetic resonance cholangiopancreatography
(MRCP) or endoscopic retrograde cholangiopancreatography
(ERCP), upper gastrointestinal endoscopy (UGIE) and Doppler
ultrasonography (Doppler USG). The preferred cholangiographic
study for assessment of the biliary obstruction was MRCP. The
diagnosis of EHPVO was based on the Doppler USG finding of
replacement of the portal vein by a portal cavernoma. Doppler
USG was also utilized to determine the size and patency of the
splenic vein, the superior mesenteric vein, the hepatic veins and
the left renal vein, and for assessment of collaterals. Oesophageal
varices were classified according to the grading system of Conn
and Brodoff (Grade 1, small varices appearing on Valsalva
manoeuvre only; Grade 2, varices of 1–3 mm in diameter appear-
ing without Valsalva manoeuvre; Grade 3, variceal diameter
3–6 mm; Grade 4, variceal diameter >6 mm).13 In some patients
presenting with cholangitis or high bilirubin levels, endoscopic
biliary stent placement was necessary prior to shunt surgery.
The management protocol of these patients included two
stages. In the first stage, patients underwent a portal decompres-
sive procedure in the form of proximal splenorenal shunt (PSRS)
surgery to decompress the portal cavernoma responsible for the
biliopathy. Intraoperative assessment of the suitability and feasi-
bility of the procedure was performed. Following splenectomy, the
splenic vein was dissected to obtain an adequate length and a
splenic-vein-to-left-renal-vein shunt was formed in an end-to-
side fashion with a 5–0 or 6–0 polypropylene suture. Intraopera-
tive portal pressure was measured at the omental branch of the
gastroepiploic vein at the beginning and after completion of the
shunt to assess the adequacy of the shunt. Intraoperative Tru-Cut
liver biopsy was performed. Intraoperative blood loss and dura-
tion of surgery were noted. Postoperative blood transfusion
requirements, period of intensive care unit (ICU) stay, LFTs,
morbidity and mortality were recorded.
Six weeks after shunt surgery, the patients were re-evaluated for
the resolution of symptoms and improvement in LFTs. Shunt
patency was assessed by Doppler USG and UGIE was performed
to assess any resolution or regression in the grade of varices.
Regression in variceal status by more than one grade was taken as
an indirect indicator of shunt patency. Venography was not used
routinely to assess shunt patency because of its invasiveness.
Patients without any dominant biliary abnormality on preop-
erative imaging and without biliary symptoms were followed up
by clinical evaluation, LFTs and Doppler USG at 3-monthly
intervals for 2 years and 6-monthly thereafter. Patients with
dominant biliary abnormalities or persistent biliary symptoms
during follow-up underwent cholangiographic study, preferably
MRCP, which was compared with preoperative imaging. Patients
with persistent strictures were scheduled for surgical biliary
drainage procedure. Patients with intraluminal obstruction
caused by biliary calculi or sludge, but without any biliary stric-
ture, underwent endoscopic management. Indications for
second-stage surgery therefore included persistence of a domi-
nant biliary stricture, failure of endoscopic clearance of common
bile duct (CBD) calculi, non-resolution of jaundice along with
elevated LFTs, and symptomatic cholelithiasis. These patients
were studied for their symptoms, indication and type of second-
stage surgery, operative findings, duration of surgery, intraopera-
tive blood loss, intraoperative and postoperative blood
transfusion requirements, morbidity and mortality. Regular
follow-up at 3-monthly intervals with serial LFTs and abdominal
USG was maintained.
Results
A total of 311 patients with portal hypertension, including 177
patients with EHPVO, underwent surgical treatment for portal
hypertension during the study period. Among the patients with
EHPVO, 39 patients (27 males, 12 females) with symptomatic PBP
were treated surgically during this period. These patients consti-
tute the study group. The mean age of these patients was 29.6 
12.5 years (range: 13–56 years). The clinical features of these
patients, including their various presenting symptoms, physical
findings and profiles of biliary obstructive symptoms, are listed in
Table 1. Fifteen (38.5%) patients had undergone endoscopic ret-
rograde cholangiography (ERC) and stenting, mostly for the man-
agement of acute cholangitis that was unresponsive to antibiotics.
The number of stent procedures carried out in each patient in this
group ranged from one to five (mean 2.1  1.4). A history of
upper gastrointestinal haemorrhage was present in 33 (84.6%)
patients. Upper gastrointestinal tract bleeding preceded jaundice
in 23 patients by a mean of 9.2  7.4 years (range: 1–28 years).
Twenty-three patients of these 33 patients (69.7%) had undergone
endoscopic therapy for varices prior to admission. Six (15.4%)
patients were non-bleeders and exhibited jaundice as their sole
presentation; EHPVO was diagnosed in all of these during the
evaluation of jaundice. Prior to diagnosis, these patients had expe-
rienced recurrent jaundice for a mean of 8.6  5.4 years (range:
1.5–14 years).
34 HPB
HPB 2011, 13, 33–39 © 2010 International Hepato-Pancreato-Biliary Association
Investigations
Serum bilirubin and alkaline phosphatase were elevated in most of
the patients (mean serum bilirubin 4.9 3.7 mg/dl; mean serum
alkaline phosphatase 575 307 IU/l), whereas serum AST (aspar-
tate aminotransferase) and ALT (alanine aminotransferase) were
within normal limits in most patients. Mean serum albumin was
3.8  0.5 mg/dl (range: 2.7–4.8 mg/dl). Prothrombin time (PT)
was found to be abnormal in 11 patients and was easily correct-
able. Abdominal USG findings are summarized in Table 2.
Doppler USG confirmed the presence of portal cavernoma in
all patients and the patency of the splenic vein in 38 patients
(97.4%). In one patient, the splenic vein was well visualized proxi-
mally but not distally, which, along with the presence of collaterals
in the region of the superior mesenteric vein, indicated extensive
splenoportal venous thrombosi. This patient underwent hepati-
cojejunostomy without prior shunt surgery.
Cholangiographic studies were evaluated with the aim of diag-
nosing, characterizing and categorizing the PBP changes (Fig. 1).
Intrahepatic biliary radicle dilatation (all 100%), predominantly
involving the left system, was present in all patients and ectasia of
the extrahepatic biliary system was present in 79.5% of patients.
Fifteen patients (38.5%) had dominant biliary strictures (Bismuth
type I-9 and type II-6)14 and four patients had multiple strictures.
None of the patients had intrahepatic biliary strictures. Other
abnormalities noted included angulations (n = 8, 20.5%), inden-
tations (n = 16, 41.0%), filling defects (n = 12, 30.8%), calibre (n =
11, 28.2%) or outline (n = 17, 43.6%) irregularities and external
compression (n = 7, 17.9%).
All patients had documented oesophageal/gastric varices at
admission. One patient (2.6%) had completely obliterated varices,
whereas the remaining patients (38) had oesophageal grade 1–4
varices. In addition, 21 patients had undergone ERC (with or
without stent insertion) prior to admission.
Management
Surgical procedures
All 39 patients were investigated with a view to shunt surgery as
the first stage of management. Two patients could not undergo
Table 1 Salient clinical features of symptomatic portal biliopathy
patients presenting for surgical management
Clinical feature
History of jaundice, n (%) 39 (100%)
Jaundice at presentation, n (%) 28 (71.8%)
Jaundice as sole presentation, n (%) 6 (15.4%)
History of cholangitis, n (%) 24 (61.5%)
Number of cholangitis episodes, mean (range) 6.3  5.5 (1–25)
Variceal bleed, n (%) 33 (84.6%)
Abdominal pain, n (%) 24 (61.5%)
Palpable spleen, n (%) 34 (87.2%)
Symptomatic splenomegaly, n (%) 3 (7.6%)
Hypersplenism, n (%) 7 (17.9%)
Hepatomegaly, n (%) 25 (64.1%)
Ascites (mild), n (%) 1 (2.6%)
Peripheral signs of liver cell failure, n 0
Table 2 Findings on ultrasonography
Finding Patients, n (%)
Dilated intrahepatic biliary radicles 37 (94.9%)
Dilated common bile duct 32 (82.1%)
Gallstones 12 (30.8%)
Bile duct stones 7 (17.9%)
Splenomegaly 39 (100%) (massive
enlargement: 12 [30.8%])
Ascites 3 (7.7%)
Liver echotexture alteration 9 (23.1%)
(A)
(B)
Figure 1 MRCP findings in portal biliopathy
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PSRS in the first stage. One patient with endoscopic management
failure for recurrent cholangitis and choledocholithiasis was con-
sidered to have extensive splenoportal venous thrombosis, which
precluded shunt surgery; this patient underwent biliary surgery
directly. Another patient was found to have a small, shrunken,
nodular liver on intraoperative assessment and was considered
unsuitable for shunt surgery in view of an associated higher inci-
dence of postoperative liver decompensation and clinical/
subclinical hepatic encephalopathy in the long term; this patient
underwent oesophagogastric devascularization with hepaticoje-
junostomy instead.
First-stage surgery: PSRS
Thirty-seven (94.9%) patients underwent PSRS as the first phase
of management. Perioperative results are summarized in Table 3.
Six (16.2%) patients required postoperative ventilatory support
for a mean of 1.7 days. Mean ICU and hospital stays were 2.7 1.3
days and 6.6  3.1 days, respectively. There was no mortality in
the postoperative period. One patient required re-exploration for
an intra-abdominal bleed on the first postoperative day and recov-
ered well thereafter. None of the patients demonstrated
any increased disturbance of liver function or post-shunt
encephalopathy.
Follow-up after PSRS
In the 37 patients who underwent PSRS, shunt patency was
assessed by Doppler USG to visualize direct evidence of shunt
patency or to provide indirect evidence of shunt patency by dem-
onstrating hepatofugal flow, and UGIE to evaluate the decrease in
size or disappearance of varices. When these two studies were
evaluated in combination, 36 patients (97.3%) were considered to
have patent shunts during the follow-up after PSRS. Twelve of 13
patients (92.3%) undergoing second-stage surgery were consid-
ered to have patent shunts. Shunt patency in the remaining patient
was considered to be doubtful on Doppler USG.
The most common symptoms observed during follow-up were
cholangitis (n = 14, recurrent in 12 patients) and abdominal pain
(n = 7). Endoscopic management was carried out in 10 patients
for recurrent cholangitis (n = 4), CBD calculi (n = 3), and for both
CBD calculi and cholangitis (n = 3). It was successful in two
(20.0%) patients and was considered to have failed in eight
(80.0%).
Fourteen patients continued to have persistently abnormal
LFTs during follow-up. These patients had a persistent dominant
biliary abnormality in the form of stricture (n = 13) or angulation
(n = 1). Dominant biliary abnormalities noticed on preoperative
imaging did not show any significant reversal. No significant pro-
gression in these abnormalities was observed in most of these
patients.
Out of these 14 patients, 13 proceeded to second-stage biliary
surgery. One patient with a biliary stricture underwent successful
endoscopic clearance of CBD stones with normalization of LFTs
during the follow-up period. The procedures performed included
12 biliary drainage procedures (hepaticojejunostomy [n = 11],
choledochoduodenostomy [n = 1]). These patients had dominant
strictures (n = 11) and angulation of CBD (n = 1). The remaining
patient underwent successful endoscopic clearance of CBD stones
after first-stage surgery and required only cholecystectomy in the
second stage for gallstones. The median time between first- and
second-stage surgery was 6.1 months.
The mean duration of second-stage surgery was 4.5  2.0 h.
Mean blood loss was 280  300 ml. Blood transfusion was
required in only two patients intraoperatively and in three
patients postoperatively. Postoperative complications occurred in
11 patients. These included postoperative pyrexia (n = 6), minor
wound infection (n = 8), ascites (n = 2) and biliary leak (n = 2).
None of these patients required any surgical or radiologic inter-
ventions for these complications and all were managed conserva-
tively. There was no postoperative mortality. Two patients have
been lost to follow-up. The remaining patients are asymptomatic
and well after a mean follow-up of 32 months (range: 5–129
months).
Discussion
Portal biliopathy is reported in 80–100% cases of EHPVO1–4 and,
as EHPVO accounts for 40% of portal hypertension cases in
India,5,6 PBP cases are more commonly seen in this country than
in Western nations. Portal biliopathy manifests with symptoms of
biliary obstruction in only 5–14% of cases.1,3,7,8 In the present
series, symptomatic PBP constituted 22% of surgically treated
EHPVO cases. The reason for this relatively higher proportion
may relate to the fact that the present series consists of only
surgically treated EHPVO and PBP patients and may not reflect
the actual percentage of EHPVO patients with symptomatic PBP.
Many pathogenic mechanisms are postulated to cause PBP
changes; these include the opening up and dilatation of the epic-
holedochal15 and pericholedochal16 venous plexuses pressing on
the thin and pliable bile ducts,7,17,18 the formation of new vessels
and connective tissue resulting in solid tissue around the
ducts,7,19,20 and an extension of the thrombotic process to small
venules of the bile ducts causing ischaemia of the bile duct3,18 and
Table 3 Perioperative results of proximal splenorenal shunt surgery
Result
Duration of surgery, mean 5.5  1.6 h
Intraoperative blood loss, mean 383  318 ml
Intraoperative blood transfusions, mean 0.99  0.98 U
Fever, n (%) 12 (32.4%)
Wound infection, n (%) 7 (18.9%)
Postoperative intra-abdominal bleed, n (%) 1 (2.7%)
Ascites, n (%) 5 (13.5%)
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possibly giving rise to ischaemic cholangitis.21 These processes
may lead to stasis, cholangitis, choledocholithiasis1 and stricture
formation.3 A combination of these lead to the multitudinous
cholangiographic abnormalities seen in PBP.1–3,7–8,22–23
Multiple treatment options have been described in the litera-
ture. Endoscopic management has been reported to be
successful,24–27 although it may be hazardous if interventions such
as papillotomy, dilatation or stone extraction are performed in the
presence of collaterals in the region.28,29 In addition, although
endoscopic management may temporarily relieve the biliary
obstruction, it does not treat its underlying cause and cannot
therefore be expected to be effective in the long term. Direct
surgical approaches to the biliary system in EHPVO are also haz-
ardous as a result of the presence of collaterals in the region. By
decompressing these collaterals, total porto-systemic shunt
surgery usually relieves the choledochal obstruction in PBP and,
even in those with persistent biliary obstruction after shunt
surgery, access to the region is possible.30,31 It also makes endo-
scopic management, if required, less hazardous and has the advan-
tage of being a one time treatment option for these relatively
young patients with long life expectancies, which deals with the
symptomatic splenomegaly and hypersplenism they display.32–34
The various mechanisms postulated to cause biliary obstruc-
tion in PBP do not seem to be mutually exclusive, but it is possible
that pressure effects predominate, at least in the early stages. This
is reflected in the results of shunt surgery in these patients. Biliary
obstruction in PBP has been reported to be relieved by shunt
surgery.30,31,34 In case series dealing with the surgical management
of PBP, large proportions of patients with symptomatic PBP have
been reported to be relieved of biliary obstruction with decom-
pression of portal cavernoma; three of seven patients in an earlier
series reported from our institution30 and five of 10 patients in
another series31 were relieved by shunt surgery alone. In the
present series, more than half the patients were satisfactorily
relieved of biliary obstruction after the shunt procedure alone.
In the present series, a third of patients undergoing PSRS were
not relieved of biliary obstruction by shunt surgery alone. The
likely explanation for this is that biliary obstruction in these
patients was not caused by the pressure of collaterals on bile ducts
alone, and scarring or encasement leading to angulation3 or stric-
ture formation had already occurred. Reported rates of second-
stage surgery in other series dealing with the surgical management
of symptomatic PBP are 40–50%.30,31
Overall, the results of PSRS in the present series were satisfac-
tory, with no mortality and minimal morbidity. As hepatic func-
tion is almost always preserved in EHPVO, PSRS does not usually
lead to hepatic decompensation in these patients.35 As well as
decompressing the portal cavernoma, a total shunt such as PSRS
acts by decompressing the oesophagogastric varices, thereby
reducing the risk of variceal haemorrhage36 and hypersplenism.37
Its associated safety, low morbidity and mortality rates and ability
to deal with the other problems that arise in EHPVO make PSRS
a suitable surgical procedure in this setting.
In the presence of portal cavernoma, a direct surgical
approach to the bile ducts is difficult and hazardous, and leads
to increased blood loss, morbidity and mortality.26,30,31,38,39 A
PSRS decompresses the collaterals in the region and renders
biliary surgery safer.30,31 In the present study, average blood loss,
duration of surgery and perioperative blood transfusion require-
ments were low in the 13 patients who underwent biliary surgery
in the second stage of treatment, and 10 patients did not require
any blood transfusions. In the two patients who underwent
biliary surgery without prior shunts, these outcomes were less
satisfactory. Thus, even in patients in whom biliary obstruction
is not relieved by shunt surgery, the decompression of collaterals
makes subsequent access to bile ducts easier and safer. In an
earlier surgical series reported from our department, two
patients underwent direct biliary surgery without prior shunt
procedure. Both these patients had excessive bleeding; one died
after surgery and the other developed narrowing of the chole-
dochojejunostomy.30 These problems led us to approach the
biliary system with extreme caution in patients in whom prior
shunt surgery was not possible, as in the two patients in the
present series mentioned above, by meticulously ligating collat-
erals in the region and placing multiple sutures while opening
the duct in order to take care of the intraductal wall collaterals.
The latter often contribute significantly to the difficulty and
hazards of direct biliary surgery in these patients. Although
accessing the left duct for hepaticojejunostomy may not itself be
very difficult, excessive bleeding may occur when the duct is
opened as a result of intraductal wall collaterals. Therefore, even
if one-stage hepaticojejunostomy is technically possible, albeit
with greater and potentially higher risk for morbidity, it is not
an advocated or preferred option.
Endoscopic management of symptomatic PBP has also been
advocated in the literature.24–27,40,41 However, as well as being haz-
ardous to perform in the presence of collaterals,28,29 endoscopic
management is not very effective for longterm relief of biliary
obstruction. As the predominant mechanism appears to be pres-
sure from enlarged collaterals, procedures such as endoscopic
dilatation and stent placement, which do not decompress these
collaterals, are unlikely to lead to longterm relief of biliary
obstruction. In addition, stents are likely to become blocked,
require frequent changes,9 or need to be retained for prolonged
periods,42 causing inconvenience and risk to these patients.
Incomplete decompression of the biliary system as a result of stent
blockages is also possible and may lead to secondary biliary cir-
rhosis (SBC)9 and recurrent cholangitis. In our series, 14 patients
underwent a total of 30 ERC procedures and stent placements
prior to being referred for surgical intervention. During the
follow-up period after PSRS, endoscopic interventions for various
indications were performed in nine patients, but outcomes were
successful in only two of these and the main reason for failure was
biliary strictures. After shunt surgery, most patients without stric-
tures either did not require endoscopic interventions or, if they
did, the chances of success were higher.
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Patients with dominant biliary strictures more often required
biliary drainage surgery in the second stage. Patients with stric-
tures were significantly older than those without strictures, which
indicates that the development of strictures is a relatively later
occurrence in PBP. This underlines the importance of early rec-
ognition and intervention in symptomatic PBP patients to avoid
the formation of strictures and the need for biliary drainage
surgery with its attendant morbidity.
Patients with symptomatic PBP have been reported to be
older and to have a longer duration of disease than asymptom-
atic PBP patients.9,12,43 The mean age of patients at presentation
in this series was just under 30 years, which is higher than the
mean age at presentation of EHPVO patients, who often present
with variceal bleeding in first two decades of life.5,6,44 Abnormal
LFTs can be present without overt jaundice or cholangitis.
Therefore, patients with EHPVO should be evaluated routinely
for PBP. The subset of patients with asymptomatic PBP and
abnormal LFTs needs to be studied to ascertain whether abnor-
mal LFTs alone should represent an indication for surgery to
protect the liver from the effects of prolonged subclinical biliary
obstruction.
An algorithmic approach to the management of symptomatic
PBP patients has been proposed30,31 (Fig. 2). The results of this
series lend support to this approach. Patients with symptomatic
PBP should undergo PSRS as the first stage of management. In the
present study, the optimal time after PSRS for which the patient
should be observed for relief of biliopathy symptoms could not be
studied because many patients did not comply with the observa-
tion period proposed. However, this period should not be overly
long in order to avoid the deleterious effects of prolonged biliary
obstruction. Patients with biliary strictures are less likely to be
relieved of obstructive symptoms with PSRS alone and therefore
should expect to undergo second-stage surgery.
The effects of asymptomatic PBP on LFTs and the natural
history of the condition need to be studied in greater detail.
Conclusions
Symptomatic PBP requires intervention. Surgical decompressive
shunt followed by biliary drainage appears to be the treatment of
choice in patients with persistent biliary obstruction. Shunt
surgery alone relieves biliary obstruction in the majority of
patients and facilitates subsequent endoscopic or surgical proce-
dures in the remaining patients.
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